Journal
BIOMEDICINES
Volume 10, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines10112913
Keywords
HI; HT; necroptosis; Nec-1; MLKL; RIPK; TNF; neuronal death; neuroinflammation; neonatal encephalopathy; therapeutics; brain injury; neurodisability; neuroprotection
Ask authors/readers for more resources
Neonatal encephalopathy caused by hypoxia-ischemia is a major cause of brain injury and neurodisability in newborns. Despite the use of hypothermia as treatment, additional neuroprotective strategies are needed. This study demonstrates the neuroprotective effect of combining Necrostatin-1 with hypothermia in a preclinical rat model of neonatal encephalopathy.
Neonatal encephalopathy (NE) caused by hypoxia-ischemia (HI) affects around 1 per 1000 term newborns and is the leading cause of acquired brain injury and neurodisability. Despite the use of hypothermia (HT) as a standard of care, the incidence of NE and its devastating outcomes remains a major issue. Ongoing research surrounding add-on neuroprotective strategies against NE is important as HT effects are limited, leaving 50% of treated patients with neurological sequelae. Little is known about the interaction between necroptotic blockade and HT in neonatal HI. Using a preclinical Lewis rat model of term human NE induced by HI, we showed a neuroprotective effect of Necrostatin-1 (Nec-1: a compound blocking necroptosis) in combination with HT. The beneficial effect of Nec-1 added to HT against NE injuries was observed at the mechanistic level on both pMLKL and TNF-alpha, and at the anatomical level on brain volume loss visualized by magnetic resonance imaging (MRI). HT alone showed no effect on activated necroptotic effectors and did not preserve the brain MRI volume. This study opens new avenues of research to understand better the specific cell death mechanisms of brain injuries as well as the potential use of new therapeutics targeting the necroptosis pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available